Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of OncoVista Innovative Therapies, Inc.
No Price
Closing Price OTC 30.04.2026:
0,0001 USD
30.04.2026 20:00
Current Prices from OncoVista Innovative Therapies, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
OVIT
USD
30.04.2026 20:00
0,0001 USD
0,00 USD
Company Profile for OncoVista Innovative Therapies, Inc. Share
OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.
